Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients

Headache

Volumn 44, Issue 7, 2004, Pages 713-718

  Rossi, Paolo ^a   Di Lorenzo, Giorgio ^a   Formisano, Rita ^b   Buzzi, M Gabriella ^a  

^a INI Grottaferrata   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cluster headache; Pain recurrence; Sumatriptan; Treatment

Indexed keywords

MELATONIN; PREDNISONE; SUMATRIPTAN; TOPIRAMATE; VERAPAMIL;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLUSTER HEADACHE; DISEASE ACTIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ADULT; CLUSTER HEADACHE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; RECURRENCE; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 3142663200     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04132.x     Document Type: Article

References (21)

1. Wilkinson M, Pfaffenrath V, Shoenen J, Diener HC, Steiner TJ. Migraine and cluster headache-their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia. 1995;15:337-357.
2. Ekbom K, Solomon S. Management of cluster headache. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:733-734.
3. Ekbom K, Hardebo JE. Cluster Headache: aetiology, diagnosis and management. Drugs. 2002;62:61-69.
4. Ekbom K, Krabbe A, Micieli G, et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Cephalalgia. 1995;15:230-236.
5. Gobel H, Linder V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology. 1998;51:908-911.
6. Hardebo JE. Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms. Headache. 1993;33:18-21.
7. Hering-Hanit R. Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache. 2000;40:41-44.
8. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders-2nd Edition. Cephalalgia. 2004;24(suppl 1):1-160.
9. Leone M, Lucini V, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996;6:494-496.
10. Centonze V, Rossi A, Causarano V, Dalfino L, Cassiano MA, Centone A, et al. Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependance and tachyphylaxis. Funct Neurol. 2000;15:167-170.
11. Serdar Turhal N. Sumatriptan overdose in episodic cluster headache: a case report of overuse without event. Cephalalgia. 2001;21:700.
12. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJ, Baber RS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
13. Saxena PR, Tfelt-Hansen P. Triptans, 5HT 1B/1D agonists in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:411-417.
14. Buzzi MG, Moskowitz MA, Peroutka SJ, Buyn B. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol. 1991;103:1421-1428.
15. Huang Z, Byun B, Matsubara T, Moskowitz MA. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11. Br J Pharmacol. 1993;108:331-335.
16. Barbanti P, Fabbrini G, Vanacore N, Pesare M, Buzzi MG. Sumatriptan in migraine with unilateral cranial autonomic symptoms. Headache. 2003;43:400-403.
17. Humphrey PPA, Feniuk W. Mode of acion of the antimigraine drug sumatriptan. Trends Pharmacol Sci. 1991;12:444-446.
18. Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia. 1991;11:165-168.
19. Lopez-Alemany M, Ferrer-Tuset C, Bernacer Alpera B. Akathisia and acute dystonia induced by sumatriptan. J Neurol. 1997;244:131-132.
20. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002;125:976-984.
21. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001;89:107-110.